Mellizyme Biotechnology Limited – Trademark Portfolio
Entity Type: 99
Mellizyme Biotechnology Limited holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include EPOCH and TOTAL BIODESIGN. The owner is based in London.
10 Finsbury Square
London EC2A1AJ , GB
Showing of trademarks Trademarks
Trademark Classifications
Mellizyme Biotechnology Limited's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Mellizyme Biotechnology Limited have?
Mellizyme Biotechnology Limited has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Mellizyme Biotechnology Limited file in?
Mellizyme Biotechnology Limited files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 40 (Treatment & Processing), Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Mellizyme Biotechnology Limited's most well-known trademarks?
Mellizyme Biotechnology Limited's registered trademark portfolio includes well-known marks such as EPOCH and TOTAL BIODESIGN. These are among 2 currently registered trademarks in the portfolio.
What is Mellizyme Biotechnology Limited's trademark registration success rate?
Mellizyme Biotechnology Limited has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.